| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $44.9M | +8.3% |
| SG&A Expense | $12.7M | -19.2% |
| Operating Income | -$57.6M | +3.6% |
| Income Tax | $0 | — |
| Net Income | -$55.8M | -0.3% |
| EPS (Basic) | -$19.65 | -887.4% |
| EPS (Diluted) | -$19.65 | -887.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.0M | -6.3% |
| Current Assets | $43.7M | -39.1% |
| Total Assets | $50.2M | -37.9% |
| Current Liabilities | $10.6M | +10.4% |
| Total Liabilities | $15.2M | -1.0% |
| Stockholders' Equity | $34.9M | -46.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.6M | -21.6% |
| Capital Expenditures | $474K | +0.0% |
| Investing Cash Flow | $25.6M | -53.8% |
| Financing Cash Flow | $22.3M | — |
| Free Cash Flow | -$50.1M | -21.3% |